Stanford Addiction Medicine Dual Diagnosis Program
Our mission is to support recovery and resilience across the lifespan
for individuals with the full range of addictive behaviors.
For an appointment, please call 650-498-9111.
If high school age or younger, please call 650-723-5511.
Addiction Medicine Dual Diagnosis Clinic
The Addiction Medicine Dual Diagnosis Clinic is an outpatient ambulatory clinic which provides evidence-based treatment for adult patients with substance use disorders (drugs and alcohol), behavioral addictions (videogames, gambling, shopping, pornography, etc), and co-occurring psychiatric disorders (depression, anxiety, psychosis, etc).
For new patients seeking an initial appointment in the Stanford Addiction Medicine Dual Diagnosis Clinic, please call 650-498-9111.
Youth Addiction Medicine Dual Diagnosis
The Recovery Clinic is an outpatient ambulatory clinic which provides clinical services for youth experiencing addiction and co-occurring psychiatric disorders.
For new patients seeking an initial appointment in the Recovery Clinic (Youth Addiction Medicine Dual Diagnosis), please call 650-723-5511.
Stanford Addiction Medicine Dual Diagnosis Clinical Team
Education and Training
Addiction Medicine Fellowship
The Stanford University Addiction Medicine Fellowship, accredited by the ACGME and the American Board of Addiction Medicine, is a one-year, advanced fellowship opportunity in addiction medicine, open to physicians who have completed any ACGME-accredited residency. We provide state-of-the-art training in the treatment of patients with addiction, including detoxification, pharmacotherapy for addiction, abstinence-based recovery models, harm-reduction recovery models, motivational interviewing, 12-Step facilitation, consultation for medical and psychiatric hospital services, and psychosocial approaches to the treatment of patients with addiction and pain.
Social Work Fellowship
Social services internship in Child and Adolescent Psychiatry serving children, families and transitional-aged youth with substance use, addiction and co-occurring mental health disorder through delivery of individual, family, group therapy and case management needs. Interns train and learn to perform biopsychosocial assessments, client-centered treatment planning, and evidenced-based practices such as Cognitive Behavioral Therapy, Motivational Interviewing, and Relapse Prevention Seeking Safety, to treat clients and families. Interns attend individual and group didactic supervision.
Addiction Medicine Postdoctoral PhD
The Stanford University Addiction Medicine Postdoctoral Fellowship, accredited by the American Psychological Association, is a one-year, advanced fellowship opportunity in clinical psychology and addiction medicine, open to psychologists who have completed an APA-accredited internship program. The Clinical Psychology Fellowship at Stanford serves as the culmination of training in psychology and is guided by the scientist-practitioner model. Postdoctoral fellows are offered diverse clinical experiences in assessment and treatment utilizing evidence-based treatments, rich didactics based on current empirical literature, opportunities for scholarly inquiry, supervision by Stanford faculty.
Taube Endowed Scholars
Taube Endowed Clinical Faculty Scholar: Brad Zicherman, MD
Dr. Zicherman is a triple board certified psychiatrist and fellowship trained in child and adolescent psychiatry, addiction psychiatry and forensic psychiatry, bringing unique expertise to this leadership role.
As a Taube Scholar, Dr. Zicherman developed the Stanford Child Psychiatry Recovery Clinic. He is also a cofounder of the Stanford “VISIT” (Vaping Information, Solutions, and Interventions Toolkit for Healthcare Providers).
Taube Endowed Research Faculty Scholar: Bonnie Halpern-Felsher, PhD
Dr. Halpern-Felsher is one of the nation’s foremost experts in youth education on smoking and vaping. Her lab is at the forefront of addressing the vaping epidemic.
Dr. Halpern-Felsher’s research involves the study of adolescents’ and young adults’ perceptions of risk, acceptability and benefits of using conventional, new, and emerging tobacco products as well as cannabis and other drugs. These findings have directly influenced her advocacy and prevention work. Dr. Halpern-Felsher’s team developed and distributed the Tobacco Prevention Toolkit, Cannabis Awareness and Prevention Toolkit, and Vaping Information, Solutions, and Interventions Toolkit for Healthcare Providers.
Taube Endowed Post-Doctoral Fellow: Adina Fischer, MD, PhD
Dr. Fischer researches the neurobiological effects of cannabis in relation to depressive symptoms in youth. She has received numerous awards to present her work at national conferences, including the Society of Biological Psychiatry, the American Academy of Child and Adolescent Psychiatry, the American College of Neuropsychopharmacology, and the Northern California Psychiatric Society.